Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_assertion type Assertion NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_head.
- NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_assertion wasGeneratedBy ECO_0000203 NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_provenance.
- NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_assertion wasDerivedFrom befree-20140225 NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_provenance.
- NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_assertion SIO_000772 15867264 NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_provenance.
- NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_assertion evidence source_evidence_literature NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_provenance.
- NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_assertion description "[We identified aberrant expression of several components of the retinoic acid (RA) signaling pathway (RARalpha, MUC4, Id-1, MMP9, uPAR, HB-EGF, HOXB6, and HOXB2), many of which are known to be aberrantly expressed in pancreatic cancer and PanIN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526881.RANfrUrxuGub7oRKX-Ksq1LF7lqaUaoaHlCo4JuIYPoLQ130_provenance.